Antiplatelet versus anticoagulant therapies in advanced age: An unfinished task
- 16 June 2006
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 110 (2) , 271-272
- https://doi.org/10.1016/j.ijcard.2005.09.034
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Current status of stroke prevention in patients with atrial fibrillationEuropean Heart Journal Supplements, 2005
- Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial FibrillationAnnals of Internal Medicine, 2004
- Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillationJournal of the American College of Cardiology, 2004
- Thromboembolic prophylaxis in nonrheumatic atrial fibrillation: utilization patterns, efficacy, and complications in a long-term follow-up of community patientsInternational Journal of Cardiology, 2004
- The Effect of Warfarin and Intensity of Anticoagulation on Outcome of Intracerebral HemorrhageArchives of internal medicine (1960), 2004
- A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the CommunityJAMA, 2003
- Validation of Clinical Classification Schemes for Predicting StrokeJAMA, 2001
- Prevalence of Diagnosed Atrial Fibrillation in AdultsJAMA, 2001
- Antithrombotic Therapy in Atrial FibrillationChest, 2001
- Antithrombotic Therapy To Prevent Stroke in Patients with Atrial FibrillationAnnals of Internal Medicine, 1999